
Angiex has announced that the US Food and Drug Administration has cleared its Investigational New Drug (IND) application for AGX101, …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

